MB05032 is primarily utilized in the field of medical research, particularly in the study of metabolic disorders. It serves as a potent inhibitor of fructose-1,6-bisphosphatase, an enzyme involved in gluconeogenesis, the process by which the body produces glucose from non-carbohydrate sources. By inhibiting this enzyme, MB05032 helps in regulating blood sugar levels, making it a valuable compound in the investigation of diabetes and related metabolic conditions. Preliminary studies also explore its potential in reducing liver fat, which may benefit patients with non-alcoholic fatty liver disease (NAFLD). Its application extends to preclinical studies where it aids in understanding the biochemical pathways and potential therapeutic strategies for managing hyperglycemia and other metabolic imbalances.